{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "marketState": "REGULAR", "exchange": "PNK", "shortName": "BRII BIOSCIENCES L", "longName": "Brii Biosciences Limited", "messageBoardId": "finmb_567313358", "exchangeTimezoneName": "America/New_York", "market": "us_market", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.5124, "firstTradeDateMilliseconds": 1642775400000, "regularMarketChange": 0.0, "regularMarketTime": 1684178218, "regularMarketDayHigh": 0.5124, "regularMarketDayRange": "0.5124 - 0.5124", "regularMarketDayLow": 0.5124, "regularMarketVolume": 335, "regularMarketPreviousClose": 0.5124, "fullExchangeName": "Other OTC", "financialCurrency": "CNY", "regularMarketOpen": 0.5124, "averageDailyVolume3Month": 35, "averageDailyVolume10Day": 100, "fiftyTwoWeekLowChange": 0.5096, "fiftyTwoWeekLowChangePercent": 182.0, "fiftyTwoWeekRange": "0.0028 - 1.25", "fiftyTwoWeekHighChange": -0.7376, "fiftyTwoWeekHighChangePercent": -0.59008, "fiftyTwoWeekLow": 0.0028, "fiftyTwoWeekHigh": 1.25, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.1, "sharesOutstanding": 727203008, "bookValue": 4.405, "fiftyDayAverage": 0.661844, "fiftyDayAverageChange": -0.14944404, "fiftyDayAverageChangePercent": -0.2257995, "twoHundredDayAverage": 0.7791145, "twoHundredDayAverageChange": -0.2667145, "twoHundredDayAverageChangePercent": -0.34233034, "marketCap": 372618816, "priceHint": 4, "priceToBook": 0.116322346, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "displayName": "Brii Biosciences", "symbol": "BRIBF"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Building 7, International Science Park", "address2": "3rd Floor, Zhongguancun Dongsheng No. 1 North Yongtaizhuang Road Haidian District", "city": "Beijing", "zip": "100192", "country": "China", "website": "https://www.briibio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Brii Biosciences Limited engages in the research and development of therapies for the treatment of infectious and central nervous system diseases primarily in China and the United States. The company develops BRII-179, BRII-835, and BRII-877, which are in Phase 2 the development of a functional cure for HBV for Hepatitis B; BRII-179, a recombinant protein-based HBV immunotherapeutic candidate that is in Phase 2; and BRII-732 that is in Phase 1 clinical trail and BRII-753, which is in preclinical stage for the treatment of HIV. It also develops BRII-296 for the treatment of PPD/MDD, anxiety, and other depressive disorders; BRII-297 for treatment of various depressive disorders; BRII-636, BRII-672, and BRII-693 for the treatment of multi-drug resistant/extensive drug resistant (MDR/XDR) gram-negative infections; and BRII-658 for oral treatment for patients with chronic NTM lung disease. The company was incorporated in 2017 and is headquartered in Beijing, China.", "fullTimeEmployees": 146, "companyOfficers": [{"maxAge": 1, "name": "Dr. Zhi  Hong Ph.D.", "age": 58, "title": "Co-founder, Exec. Chairman & CEO", "yearBorn": 1964, "fiscalYear": 2021, "totalPay": {"raw": 5563870, "fmt": "5.56M", "longFmt": "5,563,870"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ankang  Li C.F.A., J.D., Ph.D.", "age": 44, "title": "Chief Financial & Strategy Officer, Company Sec. and Exec. Director", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Eleanor  de Groot Ph.D.", "age": 53, "title": "Chief Technology Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Karen  Del Barrio Neuendorff", "age": 46, "title": "Chief People Officer & Head of HR", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Coy  Stout", "age": 50, "title": "Head of Patient Advocacy", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Li  Yan M.D., Ph.D.", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Lianhong  Xu Ph.D.", "age": 55, "title": "Head of Discovery", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Qing  Zhu Ph.D.", "age": 54, "title": "Head of China R&D", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. David  Margolis M.D., M.P.H.", "age": 47, "title": "VP & Head of Infectious Diseases Therapy Area", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Susannah  Cantrell Ph.D.", "age": 53, "title": "Chief Bus. Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}